United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 3 minute read Pharma Industry News Charles River and Akron Bio collaborate to enhance cell therapy manufacturing Charles River Laboratories International, Inc. and Akron Bio have unveiled a partnership that is poised to redefine cell… byPallavi MadhirajuJanuary 17, 2025